|
2019
|
Invention
|
Process for producing a contrast agent. The invention relates to a process for producing a contra... |
|
2018
|
Invention
|
Preparation containing a contrast agent, and method for the production thereof. The invention rel... |
|
2016
|
Invention
|
Formulation of hypericin for photodynamic therapy. A formulation which can be used as a photosens... |
|
|
Invention
|
Formulation of hypericin for photodynamic diagnosis. A formulation which can be used as a photose... |
|
2015
|
Invention
|
Method for producing a liquid pharmaceutical preparation. A method for producing a liquid pharmac... |
|
2010
|
Invention
|
Tolperisone controlled release tablet.
A GRDDS (Gastro Retentive Drug Delivery System) containin... |
|
2009
|
Invention
|
Use of galanthaminium bromide for producing ophthalmic formulations for treating glaucoma. The in... |
|
|
Invention
|
Process for manufacturing extremely pure benzazepine derivatives.
A process for the production o... |
|
2008
|
Invention
|
Compositions of tolperisone.
The present disclosure is directed to methods for providing tolperi... |
|
|
Invention
|
Compositions of tolperisone. The present disclosure is directed to methods for providing tolperis... |
|
|
Invention
|
Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), ... |
|
|
Invention
|
Method for producing salts of tolperisone.
The invention relates to a method for producing an ac... |
|
|
Invention
|
Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-e... |
|
2006
|
Invention
|
Method for isolating 5-substituted tetrazoles.
The invention relates to a method for isolating 5... |
|
|
Invention
|
Method for isolating 5-substituted tetrazoles. The invention relates to a method for isolating 5-... |
|
2005
|
Invention
|
Tolperison for treating dogs having degenerative spinal symptoms. The invention relates to a vete... |
|
|
Invention
|
Method for the preparation of crystal forms of torsemide in a pure state.
A method for the prepa... |
|
|
Invention
|
Method for the preparation of crystal forms of torsemide in a pure state. A method for the prepar... |
|
|
Invention
|
Cholinesterase inhibitors in liposomes and their production and use.
The invention relates to a ... |
|
|
Invention
|
Cholinesterase inhibitors in liposomes and their production and use. The invention relates to a p... |
|
|
Invention
|
Controlled release pharmaceutical compositions of tolperisone for oral administration.
The inven... |
|
|
Invention
|
Controlled release pharmaceutical composition of tolperisone for oral administration. The inventi... |
|
2004
|
Invention
|
Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2][2]-benzazepine, method for the pr... |
|
|
Invention
|
Pharmaceutical preparation containing tolperisone with controlled release of active substances fo... |
|
|
Invention
|
Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the ... |
|
|
Invention
|
Tolperisone-containing pharmaceutical preparation with controllable active-substance release for ... |
|
|
Invention
|
Use of galanthamine and the derivatives thereof in the production of medicaments.
The invention ... |
|
|
Invention
|
Use of galanthamine and the derivatives thereof in the production of medicaments. The invention r... |
|
|
Invention
|
Use of effectors of the central cholinergic nervous system for treatment of delirium. The inventi... |
|
2003
|
Invention
|
Method for producing salts of tolperisone. The invention relates to a method for producing an add... |
|
|
Invention
|
Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof.
The inven... |
|
|
Invention
|
Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof. The invent... |
|
2002
|
Invention
|
Derivatives and analogs of galanthamine. New compounds of general formula I
|
|
2001
|
Invention
|
Preparation of hypericin bonded with poly-n-vinylamides. The invention relates to an active agent... |
|
|
Invention
|
Novel derivatives and analogues of galanthamin. The invention relates to novel compounds of gener... |
|
1999
|
Invention
|
Use of effectors of the central cholinergic nervous system. The invention relates to the use of e... |
|
|
Invention
|
Tolperison-containing, pharmaceutical preparation for oral administration. The invention relates ... |
|
|
Invention
|
Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6h-benzofuro-[3a,3,2-ef... |
|
1998
|
Invention
|
Use of galanthamine and galanthamine derivatives in the case of acute functional brain damage. Th... |
|
|
Invention
|
Reduction of aromatic halogenides. The invention relates to the reduction of (hetero)aromatic hal... |
|
1977
|
P/S
|
Produits chimico-pharmaceutiques. |
